HOB Biotech Group Corp.,Ltd. operates as an in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-...
Hob Biotech collaborates with Roche Diagnostics in the field of chemiluminescent autoantibody detection products
Hob Biotech: MM09 sublingual spray Phase III clinical trial completes enrollment of the first batch of subjects
Hob Biotech released its semi-annual performance, with a net profit attributable to the parent company of 12.17 million yuan, a year-on-year decrease of 39.1%
Hob Biotech plans to sell part of its land use rights and factory buildings for 19.52 million yuan
Medical device concept stocks continue to rise, Hob Biotech hits the 20% limit up in the afternoon
The medical device sector saw a short-term surge, with NANFANG MEDICAL hitting the daily limit